Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine

FILE PHOTO: The Pfizer logo is pictured outside a Pfizer office amid the coronavirus disease (COVID-19) outbreak in Brussels, Belgium January 21, 2021. REUTERS/Yves Herman/File Photo GLOBAL BUSINESS WEEK AHEAD

(Reuters) – Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.

The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.

Source: Read Full Article